Orchid Pharma informs about disclosure on related party transactions

26 May 2022 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it enclosed the disclosure on Related Party Transactions, on a consolidated basis, prepared in accordance with the applicable accounting standards for the half year ended March 31, 2022. This disclosure will also be made available on the website of the Company and can be accessed using the link http://www.orchidpharma.com/invr_intimation.aspx.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

1018.00 -24.85 (-2.38%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.